US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist

1.140
+0.020+1.79%

Trading Jul 9 13:19 ET

28.69MMarket Cap-760P/E (TTM)

Gain Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

14.96%-3.59M

-28.41%-18.87M

-44.97%-5.66M

-20.60%-3.97M

0.59%-5.02M

-72.32%-4.22M

-18.81%-14.69M

5.83%-3.9M

-50.03%-3.29M

-57.01%-5.05M

Net income from continuing operations

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

Depreciation and amortization

6.68%20.53K

30.25%83.58K

30.25%23.59K

15.04%20.51K

1.09%20.24K

134.40%19.24K

314.41%64.17K

212.89%18.11K

331.15%17.83K

827.76%20.02K

Other non cash items

-63.74%-200.15K

-85.24%-383.19K

3.74%-135.7K

-377.36%-171.11K

--45.85K

---122.24K

-506.01%-206.86K

-1,892.18%-140.97K

-77.12%-35.85K

----

Change In working capital

-8.89%416.81K

-70.81%442.23K

-512.96%-1.38M

-100.56%-5.18K

624.31%1.37M

-10.39%457.47K

559.35%1.51M

124.14%334.02K

-45.83%931.5K

-54.51%-261.16K

-Change in receivables

----

-3,682.15%-130.07K

----

105.73%3.63K

----

-Change in prepaid assets

45.70%-298.47K

249.17%174.39K

-47.03%142.32K

-62.03%183.28K

14.71%398.43K

54.79%-549.64K

76.64%-116.91K

148.60%268.66K

-20.04%482.72K

1,272.24%347.35K

-Change in payables and accrued expense

-33.47%703.59K

-160.29%-643.16K

-109.23%-976.79K

-115.34%-46.1K

-32.87%-677.85K

-39.33%1.06M

304.59%1.07M

73.71%-466.85K

-74.17%300.59K

-6,375.99%-510.18K

-Change in other current assets

----

-101.55%-2.36K

----

143.07%152.35K

--0

-Change in other current liabilities

----

-107.11%-50.53K

----

6.85%711.07K

----

-Change in other working capital

123.14%11.68K

829.45%1.09M

-1,131.70%-371.34K

-3,266.10%-140K

1,781.46%1.65M

-196.73%-50.47K

-266.22%-149.65K

30.07%-30.15K

81.59%-4.16K

-145.36%-98.33K

Cash from discontinued investing activities

Operating cash flow

14.96%-3.59M

-28.41%-18.87M

-44.97%-5.66M

-20.60%-3.97M

0.59%-5.02M

-72.32%-4.22M

-18.81%-14.69M

5.83%-3.9M

-50.03%-3.29M

-57.01%-5.05M

Investing cash flow

Cash flow from continuing investing activities

43.27%3.02M

169.19%10.22M

2,247.65%3.14M

17,002.33%1.93M

120.45%3.05M

27,026.26%2.11M

-15,582.52%-14.77M

1,305.89%133.83K

64.48%-11.41K

-66,066.32%-14.89M

Net PPE purchase and sale

--0

87.09%-15.36K

99.80%-19

98.86%-650

91.82%-3.64K

-41.15%-11.05K

-26.26%-118.95K

15.32%-9.4K

-78.00%-57.18K

-97.98%-44.55K

Net investment purchase and sale

42.53%3.02M

169.86%10.24M

2,093.62%3.14M

4,115.55%1.93M

120.54%3.05M

--2.12M

---14.66M

--143.23K

--45.77K

---14.84M

Cash from discontinued investing activities

Investing cash flow

43.27%3.02M

169.19%10.22M

2,247.65%3.14M

17,002.33%1.93M

120.45%3.05M

27,026.26%2.11M

-15,582.52%-14.77M

1,305.89%133.83K

64.48%-11.41K

-66,066.32%-14.89M

Financing cash flow

Cash flow from continuing financing activities

-119.47%-145.8K

16,147.61%12.64M

44,398.94%9.56M

753.38%134.47K

161,115.26%2.2M

2,072.16%748.91K

-100.19%-78.77K

-121.69%-21.58K

-20.58K

100.64%1.36K

Net issuance payments of debt

-5.83%-22.87K

-13.07%-89.07K

-4.62%-22.58K

-9.96%-22.63K

-1,732.13%-22.25K

43.09%-21.61K

-258.86%-78.77K

1.68%-21.58K

---20.58K

--1.36K

Net common stock issuance

--0

--12.73M

--9.58M

--157.1K

--2.22M

--770.52K

--0

Proceeds from stock option exercised by employees

--157.94K

----

--0

----

Net other financing activities

---280.87K

----

Cash from discontinued financing activities

Financing cash flow

-119.47%-145.8K

16,147.61%12.64M

44,398.94%9.56M

753.38%134.47K

161,115.26%2.2M

2,072.16%748.91K

-100.19%-78.77K

-121.69%-21.58K

---20.58K

100.64%1.36K

Net cash flow

Beginning cash position

61.10%11.83M

-80.11%7.34M

-60.55%4.3M

-55.69%6.35M

-82.49%6.02M

-80.11%7.34M

391.88%36.91M

-73.40%10.91M

-66.82%14.34M

-26.30%34.37M

Current changes in cash

47.59%-713.64K

113.53%4M

285.69%7.04M

42.68%-1.9M

101.11%221.11K

45.39%-1.36M

-200.81%-29.55M

8.99%-3.79M

-49.30%-3.32M

-477.38%-19.94M

Effect of exchange rate changes

-1,251.69%-442.5K

2,152.38%488.4K

113.78%483.25K

-36.43%-144.58K

217.72%111.31K

177.91%38.42K

-123.61%-23.8K

250.42%226.05K

-407.61%-105.97K

-535.29%-94.56K

End cash Position

77.31%10.67M

61.10%11.83M

-60.55%4.3M

-55.69%6.35M

-82.49%6.02M

-80.11%7.34M

-73.40%10.91M

-66.82%14.34M

Free cash flow

15.18%-3.59M

-27.48%-18.88M

-44.62%-5.66M

-18.56%-3.97M

1.39%-5.03M

-72.22%-4.23M

-18.87%-14.81M

5.86%-3.91M

-50.43%-3.35M

-57.29%-5.1M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	14.96%-3.59M	-28.41%-18.87M	-44.97%-5.66M	-20.60%-3.97M	0.59%-5.02M	-72.32%-4.22M	-18.81%-14.69M	5.83%-3.9M	-50.03%-3.29M	-57.01%-5.05M
Net income from continuing operations	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M	-42.98%-5.09M
Depreciation and amortization	6.68%20.53K	30.25%83.58K	30.25%23.59K	15.04%20.51K	1.09%20.24K	134.40%19.24K	314.41%64.17K	212.89%18.11K	331.15%17.83K	827.76%20.02K
Other non cash items	-63.74%-200.15K	-85.24%-383.19K	3.74%-135.7K	-377.36%-171.11K	--45.85K	---122.24K	-506.01%-206.86K	-1,892.18%-140.97K	-77.12%-35.85K	----
Change In working capital	-8.89%416.81K	-70.81%442.23K	-512.96%-1.38M	-100.56%-5.18K	624.31%1.37M	-10.39%457.47K	559.35%1.51M	124.14%334.02K	-45.83%931.5K	-54.51%-261.16K
-Change in receivables	----	-3,682.15%-130.07K	----	----	----	----	105.73%3.63K	----	----	----
-Change in prepaid assets	45.70%-298.47K	249.17%174.39K	-47.03%142.32K	-62.03%183.28K	14.71%398.43K	54.79%-549.64K	76.64%-116.91K	148.60%268.66K	-20.04%482.72K	1,272.24%347.35K
-Change in payables and accrued expense	-33.47%703.59K	-160.29%-643.16K	-109.23%-976.79K	-115.34%-46.1K	-32.87%-677.85K	-39.33%1.06M	304.59%1.07M	73.71%-466.85K	-74.17%300.59K	-6,375.99%-510.18K
-Change in other current assets	----	----	----	-101.55%-2.36K	----	----	----	----	143.07%152.35K	--0
-Change in other current liabilities	----	-107.11%-50.53K	----	----	----	----	6.85%711.07K	----	----	----
-Change in other working capital	123.14%11.68K	829.45%1.09M	-1,131.70%-371.34K	-3,266.10%-140K	1,781.46%1.65M	-196.73%-50.47K	-266.22%-149.65K	30.07%-30.15K	81.59%-4.16K	-145.36%-98.33K
Cash from discontinued investing activities
Operating cash flow	14.96%-3.59M	-28.41%-18.87M	-44.97%-5.66M	-20.60%-3.97M	0.59%-5.02M	-72.32%-4.22M	-18.81%-14.69M	5.83%-3.9M	-50.03%-3.29M	-57.01%-5.05M
Investing cash flow
Cash flow from continuing investing activities	43.27%3.02M	169.19%10.22M	2,247.65%3.14M	17,002.33%1.93M	120.45%3.05M	27,026.26%2.11M	-15,582.52%-14.77M	1,305.89%133.83K	64.48%-11.41K	-66,066.32%-14.89M
Net PPE purchase and sale	--0	87.09%-15.36K	99.80%-19	98.86%-650	91.82%-3.64K	-41.15%-11.05K	-26.26%-118.95K	15.32%-9.4K	-78.00%-57.18K	-97.98%-44.55K
Net investment purchase and sale	42.53%3.02M	169.86%10.24M	2,093.62%3.14M	4,115.55%1.93M	120.54%3.05M	--2.12M	---14.66M	--143.23K	--45.77K	---14.84M
Cash from discontinued investing activities
Investing cash flow	43.27%3.02M	169.19%10.22M	2,247.65%3.14M	17,002.33%1.93M	120.45%3.05M	27,026.26%2.11M	-15,582.52%-14.77M	1,305.89%133.83K	64.48%-11.41K	-66,066.32%-14.89M
Financing cash flow
Cash flow from continuing financing activities	-119.47%-145.8K	16,147.61%12.64M	44,398.94%9.56M	753.38%134.47K	161,115.26%2.2M	2,072.16%748.91K	-100.19%-78.77K	-121.69%-21.58K	-20.58K	100.64%1.36K
Net issuance payments of debt	-5.83%-22.87K	-13.07%-89.07K	-4.62%-22.58K	-9.96%-22.63K	-1,732.13%-22.25K	43.09%-21.61K	-258.86%-78.77K	1.68%-21.58K	---20.58K	--1.36K
Net common stock issuance	--0	--12.73M	--9.58M	--157.1K	--2.22M	--770.52K	--0	--0	--0	--0
Proceeds from stock option exercised by employees	--157.94K	----	----	----	----	--0	----	----	----	----
Net other financing activities	---280.87K	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-119.47%-145.8K	16,147.61%12.64M	44,398.94%9.56M	753.38%134.47K	161,115.26%2.2M	2,072.16%748.91K	-100.19%-78.77K	-121.69%-21.58K	---20.58K	100.64%1.36K
Net cash flow
Beginning cash position	61.10%11.83M	-80.11%7.34M	-60.55%4.3M	-55.69%6.35M	-82.49%6.02M	-80.11%7.34M	391.88%36.91M	-73.40%10.91M	-66.82%14.34M	-26.30%34.37M
Current changes in cash	47.59%-713.64K	113.53%4M	285.69%7.04M	42.68%-1.9M	101.11%221.11K	45.39%-1.36M	-200.81%-29.55M	8.99%-3.79M	-49.30%-3.32M	-477.38%-19.94M
Effect of exchange rate changes	-1,251.69%-442.5K	2,152.38%488.4K	113.78%483.25K	-36.43%-144.58K	217.72%111.31K	177.91%38.42K	-123.61%-23.8K	250.42%226.05K	-407.61%-105.97K	-535.29%-94.56K
End cash Position	77.31%10.67M	61.10%11.83M	61.10%11.83M	-60.55%4.3M	-55.69%6.35M	-82.49%6.02M	-80.11%7.34M	-80.11%7.34M	-73.40%10.91M	-66.82%14.34M
Free cash flow	15.18%-3.59M	-27.48%-18.88M	-44.62%-5.66M	-18.56%-3.97M	1.39%-5.03M	-72.22%-4.23M	-18.87%-14.81M	5.86%-3.91M	-50.43%-3.35M	-57.29%-5.1M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall